subscribeSubscribe
Vivani Medical Reports Q2 2024 Results And Business Update

Vivani Medical Reports Q2 2024 Results And Business Update
BUSINESSWIRE
13 Aug 2024
Share Share
Vivani Medical Updates On Long-Term GLP-1 Obesity Implant Program

Vivani Medical Updates On Long-Term GLP-1 Obesity Implant Program
BUSINESSWIRE
11 Jul 2024
Share Share
Vivani Gets FDA IND Clearance, Clinical Hold Lifted For GLP-1 Implant NPM-119

Vivani Gets FDA IND Clearance, Clinical Hold Lifted For GLP-1 Implant NPM-119
BUSINESSWIRE
13 Jun 2024
Share Share
UK probes GLP-1 drugs` potential suicide risks

UK probes GLP-1 drugs` potential suicide risks
Angus Liu FIERCE PHARMA
27 Jul 2023
Share Share
AstraZeneca`s once-weekly diabetes drug gets U.S. nod for children

AstraZeneca`s once-weekly diabetes drug gets U.S. nod for children
REUTERS
27 Jul 2021
Share Share
AstraZeneca sales hurt by Bydureon Bcise production constraints

AstraZeneca sales hurt by Bydureon Bcise production constraints
N. Taylor IN PHARMATECNOLOGISTS
03 Nov 2019
Share Share
Longtime Alkermes executive Elliot Ehrich joins Expansion Therapeutics

Longtime Alkermes executive Elliot Ehrich joins Expansion Therapeutics
Amirah Al Idrus FIERCE BIOTECH
13 Nov 2018
Share Share
Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk

Eli Lilly Strikes Deal for Diabetes Pill to Gain on Novo Nordisk
XCONOMY
27 Sep 2018
Share Share
EU approves AZ’ Bydureon BCise device

EU approves AZ’ Bydureon BCise device
Selina McKee PHARMA TIMES
30 Aug 2018
Share Share
Repurposing a diabetes drug to slow Parkinson’s

Repurposing a diabetes drug to slow Parkinson’s
Bradley J. Fikes FIERCE BIOTECH
23 Jul 2018
Share Share